Table 2 Sensitivity analysis of cost-of-illness for patients diagnosed and hospitalised with H5N1 influenza
From: Human H5N1 influenza infections in Cambodia 2005–2011: case series and cost-of-illness
Scenario | Medical provider costs US$ (% of row total cost) | Patient costs (% of row total cost) | Total cost US$ (% of average scenario) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Outpatient consult | Hospital bed | Oxygen | Diagnostic tests | Pharma- ceuticals | Total | Travel | Food | Loss of income | Total | ||
Minimum | 1.41 (13.4%) | 0.00 | 0.00 | 0.00 | 9.10 (86.6%) | 10.51 (100%) | 0.00 | 0.00 | 0.00 | 0.00 | 10.51 (4%) |
Average | 1.85 (0.6%) | 31.25 (10.4%) | 13.20 (4.4%) | 123.41 (41.2%) | 85.15 (28.4%) | 254.87(85.0%) | 18.88 (6.3%) | 2.41 (0.8%) | 23.54 (7.9%) | 44.82 (15.0%) | 299.69 (100%) |
Maximum | 2.82 (0.3%) | 143.30 (17.1%) | 39.12 (4.7%) | 183.17 (21.9%) | 355.16 (42.5%) | 723.57 (86.6%) | 40.00 (4.8%) | 5.86 (0.7%) | 66.22 (7.9%) | 112.09(13.4%) | 835.66 (279%) |